Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
US Stock Market Movements | Cryptocurrency-related stocks generally fall, Hut 8 (HUT.US) down over 7%

US Stock Market Movements | Cryptocurrency-related stocks generally fall, Hut 8 (HUT.US) down over 7%

智通财经智通财经2026/10/08 15:26
Show original

According to Zhihu Finance APP, on Thursday, cryptocurrency-related stocks generally fell. Hut 8 (HUT.US) dropped more than 7%, Canaan Technology (CAN.US) fell nearly 5%, SharpLink (SBET.US) slipped over 2%, and Bitmine Immersion Technologies (BMNR.US) fell nearly 2%. Strategy (MSTR.US) and Coinbase (COIN.US) both dropped more than 3% intraday, but by the time of reporting, their declines had narrowed to less than 1%. Bitcoin’s price once fell below $82,000 intraday, down nearly 2% for the day.

According to Zhihu Finance APP, on Thursday, cryptocurrency-related stocks mostly fell. Hut 8 (HUT.US) dropped over 7%, Canaan (CAN.US) fell nearly 5%, SharpLink (SBET.US) declined more than 2%, Bitmine Immersion Technologies (BMNR.US) was down almost 2%. Strategy (MSTR.US) and Coinbase (COIN.US) both fell more than 3% during intraday trading, but as of press time, their declines narrowed to less than 1%. The price of Bitcoin once fell below $82,000 intraday, down nearly 2% on the day.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%